Emma Lefrançais

4.1k total citations · 2 hit papers
15 papers, 2.8k citations indexed

About

Emma Lefrançais is a scholar working on Immunology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emma Lefrançais has authored 15 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emma Lefrançais's work include Eosinophilic Esophagitis (7 papers), IL-33, ST2, and ILC Pathways (7 papers) and Platelet Disorders and Treatments (3 papers). Emma Lefrançais is often cited by papers focused on Eosinophilic Esophagitis (7 papers), IL-33, ST2, and ILC Pathways (7 papers) and Platelet Disorders and Treatments (3 papers). Emma Lefrançais collaborates with scholars based in France, United States and United Kingdom. Emma Lefrançais's co-authors include Jean‐Philippe Girard, Mark R. Looney, Corinne Cayrol, Beñat Mallavia, Stéphane Roga, Emilie Mirey, Hanjing Zhuo, Carolyn S. Calfee, Nathalie Ortéga and Mélanie Pichery and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Emma Lefrançais

14 papers receiving 2.7k citations

Hit Papers

The lung is a site of platelet biogenesis and a reservoi... 2012 2026 2016 2021 2017 2012 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Lefrançais France 13 1.8k 912 440 427 390 15 2.8k
Emily Thornton United States 14 1.9k 1.1× 975 1.1× 420 1.0× 388 0.9× 334 0.9× 16 3.1k
Anna Šedivá Czechia 30 1.4k 0.8× 284 0.3× 515 1.2× 369 0.9× 217 0.6× 124 2.7k
Shigeto Tohma Japan 33 968 0.6× 324 0.4× 578 1.3× 409 1.0× 408 1.0× 182 3.5k
Makoto Hirokawa Japan 28 983 0.6× 321 0.4× 363 0.8× 292 0.7× 576 1.5× 121 2.6k
Sylvain Dubucquoi France 29 856 0.5× 403 0.4× 312 0.7× 288 0.7× 225 0.6× 130 3.0k
Aroldo Rizzo Italy 30 1.1k 0.6× 381 0.4× 852 1.9× 586 1.4× 513 1.3× 50 3.2k
Masahiro Yamamura Japan 27 1.4k 0.8× 328 0.4× 1.1k 2.5× 494 1.2× 469 1.2× 89 3.4k
Massimo Ghio Italy 28 1.3k 0.7× 454 0.5× 253 0.6× 399 0.9× 281 0.7× 87 2.8k
Yaoli Song United States 6 2.9k 1.6× 1.3k 1.4× 402 0.9× 160 0.4× 161 0.4× 7 3.5k
Ulf Panzer Germany 30 1.7k 1.0× 334 0.4× 380 0.9× 578 1.4× 127 0.3× 53 3.0k

Countries citing papers authored by Emma Lefrançais

Since Specialization
Citations

This map shows the geographic impact of Emma Lefrançais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Lefrançais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Lefrançais more than expected).

Fields of papers citing papers by Emma Lefrançais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Lefrançais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Lefrançais. The network helps show where Emma Lefrançais may publish in the future.

Co-authorship network of co-authors of Emma Lefrançais

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Lefrançais. A scholar is included among the top collaborators of Emma Lefrançais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Lefrançais. Emma Lefrançais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lefrançais, Emma, Denis Hudrisier, Olivier Neyrolles, Samuel M. Behar, & J. Ernst. (2025). Finding and filling the knowledge gaps in mechanisms of T cell-mediated TB immunity to inform vaccine design. Nature reviews. Immunology. 25(11). 798–815.
2.
Lefrançais, Emma, Stéphane Roga, Nathalie Ortéga, et al.. (2024). TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation. The Journal of Experimental Medicine. 221(6). 15 indexed citations
3.
Lefrançais, Emma, et al.. (2022). Occurrence and role of lung megakaryocytes in infection and inflammation. Frontiers in Immunology. 13. 1029223–1029223. 12 indexed citations
4.
Blanquart, Eve, Florence Levillain, Emma Lefrançais, et al.. (2022). ILC precursors differentiate into metabolically distinct ILC1-like cells during Mycobacterium tuberculosis infection. Cell Reports. 39(3). 110715–110715. 29 indexed citations
5.
Ortiz-Muñoz, Guadalupe, Michelle Yu, Emma Lefrançais, et al.. (2020). Cystic fibrosis transmembrane conductance regulator dysfunction in platelets drives lung hyperinflammation. Journal of Clinical Investigation. 130(4). 2041–2053. 39 indexed citations
6.
Cleary, Simon J., Carl Hobbs, Richard T. Amison, et al.. (2019). LPS-induced Lung Platelet Recruitment Occurs Independently from Neutrophils, PSGL-1, and P-Selectin. American Journal of Respiratory Cell and Molecular Biology. 61(2). 232–243. 42 indexed citations
7.
Lefrançais, Emma & Mark R. Looney. (2019). Platelet Biogenesis in the Lung Circulation. Physiology. 34(6). 392–401. 58 indexed citations
8.
Lefrançais, Emma, Beñat Mallavia, Hanjing Zhuo, Carolyn S. Calfee, & Mark R. Looney. (2018). Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury. JCI Insight. 3(3). 340 indexed citations
9.
Lefrançais, Emma, Guadalupe Ortiz-Muñoz, Axelle Caudrillier, et al.. (2017). The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 544(7648). 105–109. 767 indexed citations breakdown →
10.
Hamid, Umar Imran, Anna Krasnodembskaya, M Fitzgerald, et al.. (2017). Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS. Thorax. 72(11). 971–980. 53 indexed citations
11.
Lefrançais, Emma, Anaïs Duval, Emilie Mirey, et al.. (2014). Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. Proceedings of the National Academy of Sciences. 111(43). 15502–15507. 290 indexed citations
12.
Lefrançais, Emma, Stéphane Roga, Violette Gautier, et al.. (2012). IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proceedings of the National Academy of Sciences. 109(5). 1673–1678. 449 indexed citations breakdown →
13.
Lefrançais, Emma & Corinne Cayrol. (2012). Mechanisms of IL-33 processing and secretion: differences and similarities between IL-1 family members. European Cytokine Network. 23(4). 120–127. 91 indexed citations
14.
Pichery, Mélanie, Emilie Mirey, Pascale Mercier, et al.. (2012). Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33–LacZ Gene Trap Reporter Strain. The Journal of Immunology. 188(7). 3488–3495. 387 indexed citations
15.
Pichery, Mélanie, Jenna R. Murdoch, Benoît Foligné, et al.. (2012). Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. Gut. 62(12). 1714–1723. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026